I guess this is a topic which I've always felt strongly about, as a parent, and as a person who does extensive research on psychiatric drug markets. More and more pharmaceutical companies with branded psychopharmacologic products are turning towards the pediatric population (i.e. kids that are diagnosed with bipolar disorder, schizophrenia, major
(
Read more... )